Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 1, 2008, Pages 34-41

  Navarra, Rachel ^a   Graf, Radka ^a   Huang, Youping ^a   Logue, Sheree ^a   Comery, Thomas ^a   Hughes, Zoe ^a   Day, Mark ^a  

^a PFIZER INC   (United States)

Author keywords

5 Choice serial reaction time; Attention; Attention Deficit Hyperactivity Disorder (ADHD); Continuous performance test; Impulsivity; Translational animal models

Indexed keywords

ATOMOXETINE; METHYLPHENIDATE;

ALERTNESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BIOLOGICAL MODEL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; IMPULSIVENESS; LATENT PERIOD; LONG EVANS RAT; MALE; MOTIVATION; NONHUMAN; RAT; RESPONSE TIME; SEDATION; TASK PERFORMANCE;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ATTENTION; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOICE BEHAVIOR; DOSE-RESPONSE RELATIONSHIP, DRUG; IMPULSIVE BEHAVIOR; MALE; METHYLPHENIDATE; PROPYLAMINES; PSYCHOMOTOR PERFORMANCE; RATS; RATS, LONG-EVANS; REACTION TIME;

EID: 38349054203     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.06.017     Document Type: Article

References (59)

1. Arnsten A.F., and Cai J.X. Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys: indirect effects of yohimbine versus direct effects of clonidine. Neurobiol Aging 14 6 (1993) 597-603
2. Arnsten A.F., and Li B.M. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57 11 (2005) 1377-1384
3. Banaschewski T., Brandeis D., Heinrich H., Albrecht B., Brunner E., and Rothenberger A. Association of ADHD and conduct disorder - brain electrical evidence for the existence of a distinct subtype. J Child Psychol Psychiatry 44 3 (2003) 356-376
4. Banaschewski T., Siniatchkin M., Uebel H., and Rothenberger A. Compulsive phenomena in children with tic disorder and attention deficit-hyperactive disorder. Z Kinder Jugendpsychiatr Psychother 31 3 (2003) 203-211
5. Baunez C., and Robbins T.W. Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat. Neuroscience 92 4 (1999) 1343-1356
6. Baxter D., and Appleby L. Case register study of suicide risk in mental disorders. Br J Psychiatry 175 (1999) 322-326
7. Biederman J., and Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 366 9481 (2005) 237-248
8. Bizarro L., Patel S., Murtagh C., and Stolerman I.P. Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate. Behav Pharmacol 15 3 (2004) 195-206
9. Bromley E. A collaborative approach to targeted treatment development for schizophrenia: a qualitative evaluation of the NIMH-MATRICS project. Schizophr Bull 31 4 (2005) 954-961
10. Buchanan R.W., Davis M., Goff D., Green M.F., Keefe R.S., Leon A.C., et al. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull 31 1 (2005) 5-19
11. Butler G.K., and Montgomery A.M. Subjective self-control and behavioural impulsivity coexist in anorexia nervosa. Eat Behav 6 3 (2005) 221-227
12. Bymaster F.P., Katner J.S., Nelson D.L., Hemrick-Luecke S.K., Threlkeld P.G., Heiligenstein J.H., et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27 5 (2002) 699-711
13. Cai J.X., Ma Y.Y., Xu L., and Hu X.T. Reserpine impairs spatial working memory performance in monkeys: reversal by the alpha 2-adrenergic agonist clonidine. Brain Res 614 1-2 (1993) 191-196
14. Carli M., Robbins T.W., Evenden J.L., and Everitt B.J. Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9 3 (1983) 361-380
15. Cole B.J., and Robbins T.W. Dissociable effects of lesions to the dorsal or ventral noradrenergic bundle on the acquisition, performance, and extinction of aversive conditioning. Behav Neurosci 101 4 (1987) 476-488
16. Cole B.J., and Robbins T.W. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res 33 2 (1989) 165-179
17. Coull J.T., Middleton H.C., Robbins T.W., and Sahakian B.J. Clonidine and diazepam have differential effects on tests of attention and learning. Psychopharmacology (Berl) 120 3 (1995) 322-332
18. Dalley J.W., McGaughy J., O'Connell M.T., Cardinal R.N., Levita L., and Robbins T.W. Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task. J Neurosci 21 13 (2001) 4908-4914
19. Dalley J.W., Theobald D.E., Pereira E.A., Li P.M., and Robbins T.W. Specific abnormalities in serotonin release in the prefrontal cortex of isolation-reared rats measured during behavioural performance of a task assessing visuospatial attention and impulsivity. Psychopharmacology (Berl) 164 3 (2002) 329-340
20. Dalley J.W., Theobald D.E., Bouger P., Chudasama Y., Cardinal R.N., and Robbins T.W. Cortical cholinergic function and deficits in visual attentional performance in rats following 192 IgG-saporin-induced lesions of the medial prefrontal cortex. Cereb Cortex 14 8 (2004) 922-932
21. Dervaux A., Bayle F.J., Laqueille X., Bourdel M.C., Le Borgne M.H., Olie J.P., et al. Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia?. Am J Psychiatry 158 3 (2001) 492-494
22. Dervaux A., Bayle F.J., Laqueille X., Bourdel M.C., Le Borgne M.H., Olie J.P., et al. Nicotine use in schizophrenia and disinhibition. Psychiatry Res 128 3 (2004) 229-234
23. Egeland J., Rund B.R., Sundet K., Landro N.I., Asbjornsen A., Lund A., et al. Attention profile in schizophrenia compared with depression: differential effects of processing speed, selective attention and vigilance. Acta Psychiatr Scand 108 4 (2003) 276-284
24. El-Ghundi M., Fletcher P.J., Drago J., Sibley D.R., O'Dowd B.F., and George S.R. Spatial learning deficit in dopamine D(1) receptor knockout mice. Eur J Pharmacol 383 2 (1999) 95-106
25. Epstein J.N., Conners C.K., Hervey A.S., Tonev S.T., Arnold L.E., Abikoff H.B., et al. Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry 47 5 (2006) 446-456
26. Evenden J. Impulsivity: a discussion of clinical and experimental findings. J Psychopharmacol 13 2 (1999) 180-192
27. Everitt B.J., and Robbins T.W. Central cholinergic systems and cognition. Annu Rev Psychol 48 1 (1997) 649-684
28. Gibbs S.E., and D'Esposito M. A functional MRI study of the effects of bromocriptine, a dopamine receptor agonist, on component processes of working memory. Psychopharmacology (Berl) 180 4 (2005) 644-653
29. Gibbs S.E., and D'Esposito M. Individual capacity differences predict working memory performance and prefrontal activity following dopamine receptor stimulation. Cogn Affect Behav Neurosci 5 2 (2005) 212-221
30. Granon S., Passetti F., Thomas K.L., Dalley J.W., Everitt B.J., and Robbins T.W. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 20 3 (2000) 1208-1215
31. Green M.F., and Nuechterlein K.H. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr Res 72 1 (2004) 1-3
32. Lapiz M.D., and Morilak D.A. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 137 3 (2006) 1039-1049
33. Lee J., and Park S. The role of stimulus salience in CPT-AX performance of schizophrenia patients. Schizophr Res 81 2-3 (2006) 191-197
34. Levinoff E.J., Saumier D., and Chertkow H. Focused attention deficits in patients with Alzheimer's disease and mild cognitive impairment. Brain Cogn 57 2 (2005) 127-130
35. Loo S.K., Hopfer C., Teale P.D., and Reite M.L. EEG correlates of methylphenidate response in ADHD: association with cognitive and behavioral measures. J Clin Neurophysiol 21 6 (2004) 457-464
36. Martin C.S., Earleywine M., Blackson T.C., Vanyukov M.M., Moss H.B., and Tarter R.E. Aggressivity, inattention, hyperactivity, and impulsivity in boys at high and low risk for substance abuse. J Abnorm Child Psychol 22 2 (1994) 177-203
37. Mass R. The vigilance paradigm in schizophrenia research - studies on the Continuous Performance Test (CPT). Fortschr Neurol Psychiatr 70 1 (2002) 34-39
38. McGaughy J., Dalley J.W., Morrison C.H., Everitt B.J., and Robbins T.W. Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusions of 192 IgG-saporin on attentional performance in a five-choice serial reaction time task. J Neurosci 22 5 (2002) 1905-1913
39. Morton W.A., and Stockton G.G. Methylphenidate abuse and psychiatric side effects. Prim Care Companion J Clin Psychiat 2 5 (2000) 159-164
40. Muir J.L., Page K.J., Sirinathsinghji D.J., Robbins T.W., and Everitt B.J. Excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention. Behav Brain Res 57 2 (1993) 123-131
41. Muir J.L., Everitt B.J., and Robbins T.W. AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J Neurosci 14 4 (1994) 2313-2326
42. Muir J.L., Everitt B.J., and Robbins T.W. Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. Psychopharmacology (Berl) 118 1 (1995) 82-92
43. Muir J.L., Bussey T.J., Everitt B.J., and Robbins T.W. Dissociable effects of AMPA-induced lesions of the vertical limb diagonal band of Broca on performance of the 5-choice serial reaction time task and on acquisition of a conditional visual discrimination. Behav Brain Res 82 1 (1996) 31-44
44. Nestor P.G., Faux S.F., McCarley R.W., Shenton M.E., and Sands S.F. Measurement of visual sustained attention in schizophrenia using signal detection analysis and a newly developed computerized CPT task. Schizophr Res 3 5-6 (1990) 329-332
45. Nieuwenstein M.R., Aleman A., and de Haan E.H. Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test. J Psychiatr Res 35 2 (2001) 119-125
46. Passetti F., Dalley J.W., O'Connell M.T., Everitt B.J., and Robbins T.W. Increased acetylcholine release in the rat medial prefrontal cortex during performance of a visual attentional task. Eur J Neurosci 12 8 (2000) 3051-3058
47. Pliszka S.R. Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management. Paediatr Drugs 5 11 (2003) 741-750
48. Potvin S., Stip E., and Roy J.Y. Schizophrenia and addiction: an evaluation of the self-medication hypothesis. Encephale 29 3 Pt 1 (2003) 193-203
49. Puumala T., Ruotsalainen S., Jakala P., Koivisto E., Riekkinen Jr. P., and Sirvio J. Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder. Neurobiol Learn Mem 66 2 (1996) 198-211
50. Retz W., Retz-Junginger P., Supprian T., Thome J., and Rosler M. Association of serotonin transporter promoter gene polymorphism with violence: relation with personality disorders, impulsivity, and childhood ADHD psychopathology. Behav Sci Law 22 3 (2004) 415-425
51. Riccio C.A., Waldrop J.J., Reynolds C.R., and Lowe P. Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci 13 3 (2001) 326-335
52. Robbins T.W. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163 3-4 (2002) 362-380
53. Robbins T.W. Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J Comp Neurol 493 1 (2005) 140-146
54. Rosa-Neto P., Lou H.C., Cumming P., Pryds O., Karrebaek H., Lunding J., et al. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage 25 3 (2005) 868-876
55. Stanley B., Gameroff M.J., Michalsen V., and Mann J.J. Are suicide attempters who self-mutilate a unique population?. Am J Psychiatry 158 3 (2001) 427-432
56. Teicher M.H., Lowen S.B., Polcari A., Foley M., and McGreenery C.E. Novel strategy for the analysis of CPT data provides new insight into the effects of methylphenidate on attentional states in children with ADHD. J Child Adolesc Psychopharmacol 14 2 (2004) 219-232
57. Tzavara E.T., Bymaster F.P., Overshiner C.D., Davis R.J., Perry K.W., Wolff M., et al. Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine. Mol Psychiatry (2005)
58. Verdoux H., Liraud F., Gonzales B., Assens F., Abalan F., and van Os J. Suicidality and substance misuse in first-admitted subjects with psychotic disorder. Acta Psychiatr Scand 100 5 (1999) 389-395
59. Volkow N.D., Wang G., Fowler J.S., Logan J., Gerasimov M., Maynard L., et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 21 2 (2001) RC121